Outcome of Medically Versus Surgically Treated Patients with Chronic Thromboembolic Pulmonary Hypertension

Clinical and Applied Thrombosis/Hemostasis

Volumn 22, Issue 1, 2016, Pages 92-99

  Wieteska, Maria ^a   Biederman, Andrzej ^b   Kurzyna, Marcin ^a   Dyk, Wojciech ^b   Burakowski, Janusz ^c   Wawrzyńska, Liliana ^c   Szturmowicz, Monika ^c   Fijałkowska, Anna ^d   Szatkowski, Piotr ^e   Torbicki, Adam ^a  

^a Centre of Postgraduate Medical Education   (Poland)

^b Allenort Medica   (Poland)

^c NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^d INSTITUTE OF MOTHER AND CHILD   (Poland)

^e INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

prognostic factors; pulmonary endarterectomy; pulmonary hypertension; pulmonary thromboembolism; right heart failure; survival

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BOSENTAN; COLD AGGLUTININ; ILOPROST; SILDENAFIL; TREPROSTINIL;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CACHEXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE SEVERITY; ENDARTERECTOMY; EPILEPSY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEMOLYTIC ANEMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTHYROIDISM; LUNG EMBOLISM; LUNG PRESSURE; LUNG SURGERY; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOTHERAPY; MORTALITY RATE; OBESITY; OUTCOME ASSESSMENT; PERICARDIAL EFFUSION; PERITONITIS; PRIORITY JOURNAL; PULMONARY ENDARTERECTOMY; SEPTIC SHOCK; SURGICAL RISK; SURVIVOR; THROMBOCYTOPENIA; THROMBOPHILIA; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE; VENA CAVA FILTER; AGED; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HYPERTENSION, PULMONARY; MIDDLE AGED; MORTALITY; PULMONARY EMBOLISM; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84951285649     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029614536604     Document Type: Article

References (29)

1. Lang IM, Klepetko W,. Update on chronic thromboembolic pulmonary hypertension, a frequently undiagnosed condition. Rev Esp Cardiol. 2009; 62 (2): 120-125.
2. Lewczuk J, Piszko P, Jagas J, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest. 2001; 119 (3): 818-823.
3. Riedel M, Stanek V, Widimsky J, Prerovsky I,. Long-term follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982; 81 (2): 151-158.
4. Doyle RL, McCrory D, Channick RN, Simonneau G, Conte J,. Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004; 126 (1 suppl): 63S-71S.
5. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the European society of cardiology (ESC). Eur Heart J. 2008; 29 (18): 2276-2315.
6. Thistlethwaite PA, Madani M, Jamieson SW,. Pulmonary thromboendarterectomy surgery. Cardiol Clin. 2004; 22 (3): 467-478.
7. Thistlethwaite PA, Kaneko K, Madani MM, Jamieson SW,. Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg. 2008; 14 (5): 274-282.
8. Archibald CJ, Auger WR, Fedullo PF, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999; 160 (2): 523-528.
9. Condliffe R, Kiely DG, Gibbs JS, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008; 177 (10): 1122-1127.
10. Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003; 76 (5): 1457-1462.
11. Mayer E, Dahm M, Hake U, et al. Mid-term results of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 1996; 61 (6): 1788-1792.
12. Saouti N, Morshuis WJ, Heijmen RH, Snijder RJ,. Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience. Eur J Cardiothorac Surg. 2009; 35 (6): 947-952.
13. Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011; 124 (18): 1973-1981.
14. Bonderman D, Skoro-Sajer N, Jakowitsch J, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation. 2007; 115 (16): 2153-2158.
15. Condliffe R, Kiely DG, Gibbs JS, et al. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009; 33 (2): 332-338.
16. Matsuda H, Ogino H, Minatoya K, et al. Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 2006; 82 (4): 1338-1343.
17. Saouti N, de MF, Westerhof N, et al. Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension. Respir Med. 2009; 103 (7): 1013-1019.
18. Bonderman D, Wilkens H, Wakounig S, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009; 33 (2): 325-331.
19. Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011; 141 (3): 702-710.
20. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS), endorsed by the International society of heart and lung transplantation (ISHLT). Eur Heart J. 2009; 30 (20): 2493-2537.
21. Thistlethwaite PA, Kemp A, Du L, Madani MM, Jamieson SW,. Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2006; 131 (2): 307-313.
22. Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004; 23 (4): 637-648.
23. Galie N, Kim NH,. Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006; 3 (7): 571-576.
24. Moser KM, Bloor CM,. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993; 103 (3): 685-692.
25. Ghofrani HA, D'Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013; 369 (4): 319-329.
26. Jais X, D'Armini AM, Jansa P, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008; 52 (25): 2127-2134.
27. Olschewski H, Simonneau G, Galie N, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002; 347 (5): 322-329.
28. Suntharalingam J, Treacy CM, Doughty NJ, et al. Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest. 2008; 134 (2): 229-236.
29. Raymond RJ, Hinderliter AL, Willis PW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol. 2002; 39 (7): 1214-1219.